Primary IVF Conditions for Registration For Assisted Reproductive Treatment Providers under the Assisted Reproductive Treatment Act 2008

Similar documents
Privacy Policy SOP-031

(Non-legislative acts) DECISIONS

MINISTRY OF HEALTH STAGE PROBITY REPORT. 26 July 2016

The Medical Examiner s Process

DNVGL-CG-0214 Edition September 2016

Fiscal 2007 Environmental Technology Verification Pilot Program Implementation Guidelines

SATELLITE NETWORK NOTIFICATION AND COORDINATION REGULATIONS 2007 BR 94/2007

Conformity assessment procedures for hip, knee and shoulder total joint replacements

SAINT VINCENT AND THE GRENADINES TELECOMMUNICATIONS (SPECTRUM MANAGEMENT) REGULATIONS 2007 ARRANGEMENT OF REGULATIONS PART I PRELIMINARY PART II

Ai Group Submission. in response to the REVIEW OF ELECTRICITY (CONSUMER SAFETY) ACT 2004 ISSUES PAPER

1 SERVICE DESCRIPTION

Jamaica Date: December 2 4, 2014

DISCIPLINE COMMITTEE OF THE COLLEGE OF NURSES OF ONTARIO. PANEL: April Plumton, RPN Chairperson Karen Laforet, RN Barbara Titley, RPN

Co-ordination of the Group of Notified Bodies for the Construction Products Directive 89/106/EEC. GNB-CPD Conference on CPR

AGREEMENT on UnifiedPrinciples and Rules of Technical Regulation in the Republic of Belarus, Republic of Kazakhstan and the Russian Federation

General Manager Assurance and Risk Management in Oakton;

Appeals Policy Council for the Accreditation of Educator Preparation th Street, N.W., Suite 400 Washington, D.C

NCRIS Capability 5.7: Population Health and Clinical Data Linkage

Registration of Births Deaths and Marriages (Amendment) Act 1985

Melbourne IT Audit & Risk Management Committee Charter

State of California Health and Human Services Agency California Department of Public Health

Kryptonite Authorized Reseller Program

Thank you for the opportunity to comment on the Audit Review and Compliance Branch s (ARC) recent changes to its auditing procedures.

Kryptonite Authorized Seller Program

THE UNIVERSITY OF AUCKLAND INTELLECTUAL PROPERTY CREATED BY STAFF AND STUDENTS POLICY Organisation & Governance

NHS CONTINUING HEALTH CARE:

LICENCE. for WEB LINKS. Check if this document is current Find similar documents StandardsWatch (info and login) Visit our website

Herefordshire CCG Patient Choice and Resource Allocation Policy

Merton Clinical Commissioning Group Constitution. [29 May] 2012

Ethics Guideline for the Intelligent Information Society

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT. pursuant to Article 294(6) of the Treaty on the Functioning of the European Union

Herts Valleys Clinical Commissioning Group. Review of NHS Herts Valleys CCG Constitution

Precious Metal Articles Act

Air Monitoring Directive Chapter 9: Reporting

Lambeth Clinical Commissioning Group

MSC - Marine Stewardship Council Medium changes to the Fisheries Certification Requirements and guidance

headspace Bairnsdale Private Practitioners: Model for Operations and Support

GATEWAY TO LEVEL 2 EXCELLENCE IN SAFEGUARDING

Checklist. Please read Circular No (CR) before completing the checklist.

Privacy Procedure SOP-031. Version: 04.01

CAMD Transition Sub Group FAQ IVDR Transitional provisions

Demand Side Response Methodology (DSR) for Use after a Gas Deficit Warning (GDW) Background. Draft Business Rules

What does the revision of the OECD Privacy Guidelines mean for businesses?

What We Heard Report Inspection Modernization: The Case for Change Consultation from June 1 to July 31, 2012

TECHNICAL AND OPERATIONAL NOTE ON CHANGE MANAGEMENT OF GAMBLING TECHNICAL SYSTEMS AND APPROVAL OF THE SUBSTANTIAL CHANGES TO CRITICAL COMPONENTS.

Medical Devices Calibration, testing, service and repair

REGULATIONS OF THE AUSTRALIAN LIMOUSIN BREEDERS' SOCIETY LIMITED December 2017 INDEX

This policy sets out how Legacy Foresight and its Associates will seek to ensure compliance with the legislation.

ART SERVICES AND ACQUISITION AGREEMENT *******************************************************************************

Section Meetings Section Material and Equipment. None Required

CENTER FOR DEVICES AND RADIOLOGICAL HEALTH. Notice to Industry Letters

Materiality. Staff Paper on Consideration of Definitions of Materiality in Financial Reporting Frameworks

Recast de la législation européenne et impact sur l organisation hospitalière

NZFSA Policy on Food Safety Equivalence:

The Medical Device Regulation: Transitioning between old and new

Final Document. Title: The GHTF Regulatory Model. Authoring Group: Ad Hoc GHTF SC Regulatory Model Working Group

INTRODUCTION TO THE RESULTS OF THE IMO PUBLIC CONSULTATION ON ADMINISTRATIVE REQUIREMENTS IN MARITIME REGULATIONS

DESIGN PRACTICE NOTE DESIGN/REVIEW REQUIREMENTS FOR TRACTION BONDING PLAN

Preparing for the new Regulations for healthcare providers

Incentive Guidelines. Aid for Research and Development Projects (Tax Credit)

Use of the Graded Approach in Regulation

Cash Converters Financial Services Guide

UK Broadband Ltd Spectrum Access Licence Licence Number: Rev: 4: 11 January 2018

MULTIPLE ENTRY CONSOLIDATED GROUP TSA USER AGREEMENT

Medical Devices cyber risks and threats

त न ब. BUREAU OF INDIAN STANDARDS Hallmarking Department, BIS. Subject: Draft BIS Hallmarking Regulations for comments

EFRAG s Draft letter to the European Commission regarding endorsement of Definition of Material (Amendments to IAS 1 and IAS 8)

IN THE MATTER OF THE REAL ESTATE SERVICES ACT DENISE RENEE DECARY

ARTICLE 11. Notification and recording of frequency assignments 1, 2, 3, 4, 5, 6, 7, 7bis (WRC-12)

COUNCIL DIRECTIVE 93/42/EEC. of 14 June concerning medical devices

RADIOCOMMUNICATIONS REGULATIONS 2001, REGULATION 8 - RECORD OF RADIO LICENCE

SAFEGUARDING ADULTS FRAMEWORK. Prevention and effective responses to neglect, harm and abuse is a basic requirement of modern health care services.

GENERAL DESCRIPTION OF THE CMC SERVICES

Table of Contents. Introduction... 1

Ch. 813 INTERACTIVE GAMING ADVERTISEMENTS CHAPTER 813. INTERACTIVE GAMING ADVERTISEMENTS, PROMOTIONS AND TOURNAMENTS TEMPORARY REGULATIONS

Client s Statement of Rights & Responsibilities*

Spectrum Licence Wireless Cable Service (500 & 600 MHz Band)

OPINION Issued June 9, Virtual Law Office

Risky Business: New Compliance Challenges for FDA-Regulated Industry

Paola Bailey, PsyD Licensed Clinical Psychologist PSY# 25263

CHIEF ENGINEER PROCEDURE MANAGEMENT OF OVERLAPPING DESIGN AGREEMENT

Patient Choice and Resource Allocation Policy. NHS South Warwickshire Clinical Commissioning Group (the CCG)

Licensing Procedures Manual for Satellite (Non-Fixed Satellite Earth Station) Applications

CHECKLIST FOR DESIGNATING AUTHORITIES DESIGNATION OF NOTIFIED LABORATORY. 1. General Requirement Complies Comments

Safety of Toys Implementing Regulation

Consumer and Community Participation Policy

Council of the European Union Brussels, 8 March 2017 (OR. en)

Product Guide Verizon Delaware LLC. Section 31 Delaware LLC Original Sheet 1. Connection With Certain Facilities of Others

Type Approval JANUARY The electronic pdf version of this document found through is the officially binding version

SAINT VINCENT AND THE GRENADINES TELECOMMUNICATIONS (LICENCE CLASSIFICATION) NOTICE, 2002 ARRANGEMENT OF SECTIONS

Continuing Healthcare Patient Choice and Resource Allocation Policy

DNVGL-CP-0338 Edition October 2015

I agree to abide by the attached Wyndham Chess Club code of conduct. Applicant Signature Date / /

FEE Comments on EFRAG Draft Comment Letter on ESMA Consultation Paper Considerations of materiality in financial reporting

ENGINEERING DRAWINGS MANAGEMENT POLICY (IFC/AS BUILTS)

About Advance Directives for Mental Health

G17 Dam Safety Processes

Office for Nuclear Regulation

Core values: we believe that the highest standard of integrity is essential in business. In all our activities, we aim to:

Transcription:

Primary IVF Conditions for Registration For Assisted Reproductive Treatment Providers under the Assisted Reproductive Treatment Act 2008 Effective: 1 June 2018

Contents SECTION 1: Background... 3 SECTION 2: Conditions for Registration... 4 Compliance with the Law....4 RTAC Accreditation... 4 Provision of Information to the Authority... 5 2.3.1 Information required under section 81(2) of the Act... 5 2.3.2 Information for annual reporting to Minister... 5 2.3.3 Donor Registers... 5 2.3.4 Developments in treatment and research... 5 2.3.1 Audits... 6 Advertising and other published information... 6 Provision of information to patients... 7 Notification of incidents... 7 SECTION 3: Term, Suspension and Further Conditions... 8 Page 2 of 8

SECTION 1: Background The Victorian Assisted Reproductive Treatment Authority (the Authority) is a statutory authority established by the Assisted Reproductive Treatment Act 2008 (Vic) (Act). The Authority has responsibility under the Act for administration of the registration system for assisted reproductive treatment (ART) providers in Victoria, monitoring programs and activities carried out under the Act, public education, promotion of research, management of the donor conception registers and a number of other matters outlined in the Act. The Authority is also required to advise the Minister regarding any contravention of the Act, the Assisted Reproductive Treatment Regulations 2009 (the Regulations) or a registered ART provider s registration, as well as any developments, whether in Victoria or elsewhere, that the Authority considers of major importance or concern with regard to research relating to infertility and treatment for infertility. For more information about the Authority s regulatory role and approach, please see the Authority s Regulator Plan, which is available at www.varta.org.au. Under the Act, a person may only carry out ART if that person is (or is under the supervision and direction of) a doctor who is carrying out the treatment on behalf of an ART provider registered under the Act, and is satisfied that the requirements of Divisions 2, 3 and 4 of Part 2 of the Act have been met. Similarly, a person may only carry out artificial insemination (AI) of a woman if that person is a doctor, and is satisfied that the requirements of Divisions 2, 3 and 4 of the Act have been met. Where these conditions make reference to a treatment procedure, the definition of treatment procedure in section 3 of the Act applies. An application for registration as an ART provider may be made to the Authority by any provider who holds an Reproductive Technology Accreditation Committee (RTAC) accreditation. The Authority may impose conditions on registration only if it considers it necessary in the public interest. Conditions imposed on an ART provider s registration must not be inconsistent with a condition imposed on the ART provider s RTAC accreditation. The Authority may also, by written notice given to a registered ART provider, suspend the provider's registration, either in whole or in part, if it believes the ART provider has contravened a condition of registration or if it is satisfied that there are reasonable grounds for the suspension. Conditions imposed on registration include the condition that a registered ART provider must ensure that its advertising and patient information is not misleading for patients, for instance, the publication of misleading comparative success rates. The Authority will publish on its website the conditions that have been imposed upon each registered ART provider s registration. Further clarification about the conditions contained in this document can be sought directly from the Victorian Assisted Reproductive Treatment Authority: Postal address: Level 30, 570 Bourke Street, Melbourne VIC 3000 Phone: (03) 8601 5250 Email: varta@varta.org.au Web: www.varta.org.au Page 3 of 8

SECTION 2: Conditions for Registration Primary IVF Conditions for Registration An application for registration as a registered ART provider in Victoria must be in the Authority s prescribed form. All registered ART providers must comply with these Conditions for Registration, as amended by the Authority from time to time, along with any other specific conditions imposed by the Authority on a registered ART provider s registration under the Act. Compliance with the Law An ART provider must comply with the Act, all regulations issued under the Act and all other applicable Victorian and Commonwealth laws and regulations. An ART provider must have appropriate governance, processes and systems in place to ensure compliance with the Act, these Conditions for Registration, its accreditation and all other applicable laws, regulations and conditions on approvals granted by the Authority and must provide evidence of the same when requested by the Authority. Designated Officers must attest to the following at the end of June each year: I, [name of designated officer], certify that [name of ART provider] has processes and systems in place which comply with the Assisted Reproductive Treatment Act 2008 (Vic), its Conditions for Registration and all other applicable laws, regulations and conditions on approvals granted by the Authority and the National Health and Medical Research Council (NHMRC) Ethical Guidelines on the use of assisted reproductive technology in clinical practice and research, 2017. The [name of ART provider] reviews these processes and systems annually to ensure that these requirements are met. Written notice has been given to the Authority as required under the Conditions of Registration of any non-compliance or other notifiable incidents which occurred during the past year. RTAC Accreditation An ART provider must be accredited by RTAC in order to be a registered ART provider in Victoria. Evidence of accreditation must be provided with the application for registration, together with a copy of the accreditation report from the RTAC Certification Body. An ART provider must notify the Authority immediately if its RTAC accreditation ceases or if RTAC imposes conditions on its accreditation. Upon receipt, an ART provider must provide the Authority with a copy of its RTAC accreditation, audit and surveillance reports and conditions, and any corrective action plans and related documentation issued to the ART provider in response to any non-conformity with the RTAC Code of Practice. Page 4 of 8

Provision of Information to the Authority An ART provider must provide the Authority with any information and documents that the Authority considers relevant to the carrying out of its functions under the Act, including (without limitation): 2.3.1 Information required under section 81(2) of the Act a) the ART provider's name; b) the address of each premises at which the ART provider carries out treatment procedures; c) the period for which the ART provider holds RTAC accreditation; d) details of the ART provider's internet site, if any; and e) any changes to that information as they arise. 2.3.2 Information for annual reporting to Minister An ART provider must provide the information that the Authority requires to report annually to the Minister for Health under section 114 of the Act, including information about treatment programs, participants in treatment procedures conducted, embryos formed, and embryos and gametes stored by the end of the third week in August or such other date as is notified by the Authority. Designated Officers must provide the following attestation when supplying such information: I, [name of designated officer], certify that [name of ART provider] has to the best of my knowledge after due and proper verification provided accurate data for the Authority s annual report. The [name of ART provider] critically reviews patient information management processes and systems annually to ensure that annual report data can be provided in a timely and reliable way. 2.3.3 Donor Registers An ART provider must provide any documents, records or information the Authority requires to exercise its powers under Part 6- Registers and access to information and Part 7- Voluntary Register and donor-linking of the Act. 2.3.4 Developments in treatment and research An ART provider must provide the Authority with a list of all adjuvant therapies offered by that ART provider or doctors who carry out treatment procedures on the ART provider s behalf by 30 August 2018. An ART provider must notify the Authority of the following: i. A new treatment procedure, treatment for infertility or research which: a) is proposed to be used in the course of a program of treatment by the ART provider or by a doctor carrying out treatment procedures on the ART provider s behalf; and b) could have a significant impact on the practice of ART or AI and/or is not in routine clinical use. This may include, but is not limited to, the use of adjuvant therapies. The Authority considers adjuvant therapies to be interventions offered in addition to ART or AI which are claimed to improve fertility and/or reproductive outcomes. Page 5 of 8

This notification must be made at least 30 days prior to the commencement of the new treatment, development or research to enable the Authority to report to the Minister in accordance with section 100(2) of the Act and perform its monitoring and public education functions under section 100(1) and (d) of the Act. By 30 June each year, an ART provider must report to the Authority of other developments which, in its opinion, will significantly impact the practice of ART or AI and/or are not in routine clinical use. This includes but is not limited to, the use of adjuvant therapies currently offered as part of a program of treatment by the ART provider or by the doctors who carry out treatment procedures on behalf of the ART provider. 2.3.5 Audits Where the Authority considers that an ART provider s processes, policies, procedures and/or systems may pose a risk to patient welfare and/or result in a contravention of the Act, Regulations or these conditions, an ART provider must at the Authority s request engage an external auditor at its own expense to conduct an audit of such processes, policies, procedures and/or systems. Prior to the audit, an ART provider must consult with the Authority regarding its choice of auditor. The Authority must approve the auditor prior to the audit being carried out. An ART provider must provide the audit report and any supporting documents to the Authority within two weeks of the report being completed. Advertising and other published information Published claims, comparisons and advertising by an ART provider must comply with section 133 the Health Practitioner Regulation National Law (Victoria) Act 2009 and have due regard to the Australian Health Practitioner Regulation Agency (AHPRA) Guidelines for Advertising Regulated Health Services. All advertising, claims and other information published or provided to the public, patients, practitioners or any other third parties must be verifiable and not likely to be misleading or deceptive, either directly, or by implication, by use of emphasis, comparison, contrast or omission in whole or in part or in any other manner. An ART provider must, on request, provide the Authority with evidence verifying published claims, comparisons or information. If the Authority considers that any published claims, comparisons or information may not have been adequately verified, or may be likely to be misleading or deceptive, the Authority may refer the matter to another Australian regulatory authority such as Australian Health Practitioner Regulation Agency and/or the Australian Consumer and Competition Commission. Page 6 of 8

(d) Designated Officers must attest to the following no later than 30 June each year: I, [name of designated officer], certify that [name of ART provider] has processes and systems in place to ensure that it complies with section 133 the Health Practitioner Regulation National Law (Victoria) Act 2009. The [name of ART provider] critically reviews advertising, claims and information for the general public, patients and others annually, verifying the accuracy of information provided with appropriate senior scientific/medical staff to ensure that the Conditions of Registration are met. Provision of information to patients An ART provider must provide its patients and the public with accessible and easilyunderstood information about the risks and benefits of adjuvant therapies and new treatment procedures that are offered, as part of a program of treatment, by the doctors who carry out treatment procedures on behalf of the ART provider, including accurate information about the evidence which demonstrates those risks and benefits. The Designated Officer of an ART provider must attest to the following at the end of June each year: I, [name of designated officer], certify that [name of ART provider] provides its patients and the public with accessible and easily-understood information about the risks and benefits of treatment procedures including new or adjuvant therapies, including accurate information about the evidence which demonstrates those risks and benefits. Notification of Incidents An ART provider must give the Authority written notice of: i) any actual or potential contravention of the Act or Regulations; ii) any actual or potential breach of its conditions for registration or conditions attached to any approval granted by the Authority; iii) any incident that is reported to RTAC as part of accreditation requirements; and iv) any contravention of the guiding principles of the Act in carrying out activities regulated by the Act, including any incident which is or is likely to be harmful to the health or wellbeing of patients, gametes or embryos (including, for example but without limitation, if incorrect gametes are used to form an embryo, an incorrect embryo is transferred to a woman in a treatment procedure, or where a number of gametes or embryos are lost through freezing unit or dry shipper failure); by the ART provider or by a doctor carrying out treatment procedures on its behalf. (d) The notification must be given as soon as practicable and no later than within two weeks after the ART provider becomes aware of the incident. The initial notification must be made using the Authority s Adverse Incident Report Form. The notification must include the following information: i) the date of the incident; ii) a description of the incident (including the type of incident, how it occurred and cause); iii) whether there was any damage to or loss of embryos; Page 7 of 8

iv) action taken (including immediate action and corrective action to avoid the incident occurring again); and v) steps taken or to be taken in relation to disclosure with patients affected by the incident. (e) (f) (f) A copy of any records, documents or information relevant to the incident must be provided on request. Where requested by the Authority, and within two months of the initial notification, or a period otherwise agreed with the Authority, the ART provider must also provide the Authority with information about corrective actions identified and implemented in response to the incident. Disclosure in relation to all incidents and the way that the ART provider communicates with its patients and persons affected by ART generally should be guided by the Australian Open Disclosure Framework. SECTION 3: Term, Suspension and Further Conditions Once granted, registration of an ART provider shall continue until terminated or suspended in accordance with the Act or the Conditions for Registration. The Authority may impose further conditions on the registration of the ART provider if the Authority considers it necessary in the public interest. These Conditions for Registration are reviewed by the Authority on a regular basis and updated where appropriate. Version history: Date effective 1 June 2018 Superseded version 30 January 2017 Page 8 of 8